Versatility of SPL7013 molecule, page-4

Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter.

“It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other indications” ~ @antibotter

It could have been an oversight, but since you are a long-term holder, know this company inside and out, and supposedly have a significant shareholding, I can only assume you were in fact being disingenuous and attempting imply a pending important SPL7013 development that simply not there as I explained in detail.

Over to you …